Premium
Pure laparoscopic right‐sided hepatectomy in the semi‐prone position for synchronous colorectal cancer with liver metastases
Author(s) -
Ida Satoshi,
Oki Eiji,
Ando Koji,
Kimura Yasue,
Yamashita Yoichi,
Saeki Hiroshi,
Ikegami Toru,
Yoshizumi Tomoharu,
Watanabe Masayuki,
Morita Masaru,
Shirabe Ken,
Kusumoto Tetsuya,
Ikeda Tetsuo,
Baba Hideo,
Maehara Yoshihiko
Publication year - 2014
Publication title -
asian journal of endoscopic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.372
H-Index - 18
eISSN - 1758-5910
pISSN - 1758-5902
DOI - 10.1111/ases.12098
Subject(s) - medicine , colorectal cancer , perioperative , surgery , prone position , hepatectomy , laparoscopy , abscess , lobe , cancer , resection , anatomy
Simultaneous resection for colorectal cancer and synchronous colorectal liver metastases ( SCRLM ) has been found to be safe and effective. However, pure laparoscopic simultaneous resection ( PULSAR ) for primary colorectal cancer and SCRLM is usually difficult, especially in the right lobe of the liver. The purpose of this study was to assess the feasibility of PULSAR for patients with primary colorectal cancer and SCRLM . Methods From J anuary 2008 to D ecember 2012, a total of 10 patients (9 men and 1woman; mean age, 64 years) underwent PULSAR for a primary tumor and SCRLM . Results Seven patients (70%) with lesions in the right lobe (segments 6, 7, and 8) successfully underwent resection with a pure laparoscopic procedure while in the left semi‐prone position. No patient was converted to conventional open surgery. The mean operative duration, volume of bleeding, and postoperative hospital stay were 606 ± 46 min, 585 ± 145 mL, and 18 ± 3.5 days, respectively. Although a liver abscess developed in one patient, no colonic complications or perioperative death occurred. Conclusion PULSAR for primary colorectal cancer and SCRLM is a feasible multidisciplinary treatment. Moreover, PULSAR can be safely and effectively performed with the patient in the semi‐prone position, even when SCRLM exists in the right lobe of the liver.